BioSpace News Archive

Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that it has scheduled its second quarter 2022 financial results and corporate update for Thursday, August 4, 2022.

iSpecimen Inc. today announced that it will report its financial results for the second quarter ended June 30, 2022, before the markets open on Thursday, August 4, 2022.

Eikon Therapeutics Inc., a biotechnology company that applies advanced engineering and high-performance computing to the identification of important new medicines, announced the execution of a lease with Alexandria Real Estate Equities, Inc.

Wenzel Spine, a leader in the development of innovative stand-alone spinal fusion technologies and diagnostic methods, announced today a notable achievement in the company’s history with the first awake spinal fusion procedure using the VariLift®-LX interbody implant.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its second quarter 2022 financial results on Wednesday, August 3, 2022, after the market closes.

Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), today announced that it has been granted a UK trademark for “Meta Score,” a term the Company plans to use as a digital biomarker for its consumer metabolic health program.

Minerva Surgical, Inc. (Nasdaq: UTRS) (“Minerva Surgical” or the “Company”), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced that the board of directors (the “Board”) of Minerva Surgical has appointed Derrick Sung, Ph.D. to serve as a Class II director, with a term expiring at the 2023 annual meeting of stockholders or until his successor has been duly elected and qualified.

Insmed Incorporated today announced that it will release its second quarter 2022 financial results on Thursday, August 4, 2022.

Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first half ended June 30, 2022, after the close of U.S. financial markets on Tuesday, August 2, 2022.

Gritstone bio, Inc. announced that it will host a conference call and webcast at 4:30pm ET on Thursday, August 4, 2022, to report its second quarter 2022 financial results, and provide a corporate update.